HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Investment analysts at Roth Capital issued their Q3 2025 earnings estimates for HIVE Blockchain Technologies in a research report issued to clients and investors on Wednesday, December 18th. Roth Capital analyst D. Aftahi forecasts that the company will earn ($0.19) per share for the quarter. Roth Capital has a “Strong-Buy” rating on the stock. Roth Capital also issued estimates for HIVE Blockchain Technologies’ Q4 2025 earnings at ($0.11) EPS, FY2025 earnings at ($0.55) EPS, Q1 2026 earnings at ($0.09) EPS, Q2 2026 earnings at ($0.03) EPS, Q3 2026 earnings at ($0.03) EPS, Q4 2026 earnings at $0.03 EPS, FY2026 earnings at ($0.11) EPS, FY2027 earnings at $0.13 EPS and FY2028 earnings at ($0.17) EPS.
A number of other research analysts also recently weighed in on the company. Northland Capmk raised HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Thursday, September 19th. Cantor Fitzgerald raised HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Tuesday, October 29th.
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
See Also
- Five stocks we like better than HIVE Blockchain Technologies
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- The Risks of Owning Bonds
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- Canadian Penny Stocks: Can They Make You Rich?
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
